Weekly versus daily dosing of atorvastatin

Journal of Family Practice

Volumn 51, Issue 4, 2002, Pages 365-366

  Iliff, R Douglas ^a  

^a NONE   (United States)

Author keywords

Atorvastatin; Cost effectiveness; Hyperlipidemia; Weekly dosing

Indexed keywords

ATORVASTATIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOSE TIME EFFECT RELATION; DRUG COST; FEMALE; HEADACHE; HUMAN; HYPERLIPIDEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ANALYSIS OF VARIANCE; COST-BENEFIT ANALYSIS; DRUG ADMINISTRATION SCHEDULE; DRUG COSTS; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; PILOT PROJECTS; PYRROLES; UNITED STATES;

EID: 0036213219     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Efficacy of alternate day dosing with atorvastatin
2. Is alternate day dosing of atorvastatin effective in managing patients with hyperlipidemia?
3. Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects
4. Tolerance and pharmacokinetics of single-dose atorvastatin, a potent inhibitor or HMG-CoA reductase, in healthy subjects
5. Prolonged inhibition of cholesterol synthesis explains the efficacy of atorvastatin
6. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)